Omnicell OMCL Stock
Omnicell Price Chart
Omnicell OMCL Financial and Trading Overview
| Omnicell stock price | 38.41 USD |
| Previous Close | 39.05 USD |
| Open | 38.69 USD |
| Bid | 28.02 USD x 200 |
| Ask | 49.52 USD x 200 |
| Day's Range | 38.57 - 39.43 USD |
| 52 Week Range | 26.85 - 55 USD |
| Volume | 756.54K USD |
| Avg. Volume | 573.23K USD |
| Market Cap | 1.76B USD |
| Beta (5Y Monthly) | 0.962 |
| PE Ratio (TTM) | 87.909096 |
| EPS (TTM) | 0.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.29 USD |
OMCL Valuation Measures
| Enterprise Value | 1.72B USD |
| Trailing P/E | 87.909096 |
| Forward P/E | 17.621868 |
| PEG Ratio (5 yr expected) | 15.4 |
| Price/Sales (ttm) | 1.4359529 |
| Price/Book (mrq) | 1.3998263 |
| Enterprise Value/Revenue | 1.406 |
| Enterprise Value/EBITDA | 23.395 |
Trading Information
Omnicell Stock Price History
| Beta (5Y Monthly) | 0.962 |
| 52-Week Change | 37.64% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 55 USD |
| 52 Week Low | 26.85 USD |
| 50-Day Moving Average | 40.97 USD |
| 200-Day Moving Average | 38.75 USD |
OMCL Share Statistics
| Avg. Volume (3 month) | 573.23K USD |
| Avg. Daily Volume (10-Days) | 793.03K USD |
| Shares Outstanding | 45.48M |
| Float | 41.94M |
| Short Ratio | 5.17 |
| % Held by Insiders | 2.22% |
| % Held by Institutions | 106.02% |
| Shares Short | 2.97M |
| Short % of Float | 7.93% |
| Short % of Shares Outstanding | 6.54% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 1.66% |
| Operating Margin (ttm) | 5.43% |
| Gross Margin | 43.87% |
| EBITDA Margin | 6.00% |
Management Effectiveness
| Return on Assets (ttm) | 1.20% |
| Return on Equity (ttm) | 1.62% |
Income Statement
| Revenue (ttm) | 1.23B USD |
| Revenue Per Share (ttm) | 26.84 USD |
| Quarterly Revenue Growth (yoy) | 14.89% |
| Gross Profit (ttm) | 537.47M USD |
| EBITDA | 73.61M USD |
| Net Income Avi to Common (ttm) | 20.43M USD |
| Diluted EPS (ttm) | 0.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 239.22M USD |
| Total Cash Per Share (mrq) | 5.26 USD |
| Total Debt (mrq) | 202.18M USD |
| Total Debt/Equity (mrq) | 16.09 USD |
| Current Ratio (mrq) | 1.495 |
| Book Value Per Share (mrq) | 27.632 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 155.88M USD |
| Levered Free Cash Flow (ttm) | 112.56M USD |
Profile of Omnicell
| Country | United States |
| State | TX |
| City | Fort Worth |
| Address | 4220 North Freeway |
| ZIP | 76137 |
| Phone | 877 415 9990 |
| Website | https://www.omnicell.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 3525 |
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Q&A For Omnicell Stock
What is a current OMCL stock price?
Omnicell OMCL stock price today per share is 38.41 USD.
How to purchase Omnicell stock?
You can buy OMCL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Omnicell?
The stock symbol or ticker of Omnicell is OMCL.
Which industry does the Omnicell company belong to?
The Omnicell industry is Health Information Services.
How many shares does Omnicell have in circulation?
The max supply of Omnicell shares is 45.48M.
What is Omnicell Price to Earnings Ratio (PE Ratio)?
Omnicell PE Ratio is 87.29545600 now.
What was Omnicell earnings per share over the trailing 12 months (TTM)?
Omnicell EPS is 0.44 USD over the trailing 12 months.
Which sector does the Omnicell company belong to?
The Omnicell sector is Healthcare.
Omnicell OMCL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
US Tech US 700 Small Cap Value I
NQUS700SCV
US
|
2667.39 USD — |
-0.08
|
— — | 2651.75 USD — | 2676.65 USD — | — - | — — |
US Tech CTA Artificial Intellige
NQROBO
US
|
1889.46 USD — |
-2.28
|
— — | 1887.18 USD — | 1923.82 USD — | — - | — — |
US Tech DM Ex Japan Large Mid Ca
NQDMXJPLMAUD
US
|
2100.38 AUD 1467.26 USD |
<0.01
|
— — | 2100.38 AUD 1467.26 USD | 2100.38 AUD 1467.26 USD | — - | — — |
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
US Tech US 700 Small Cap Value N
NQUS700SCVN
US
|
3054.14 USD — |
-0.08
|
— — | 3036.24 USD — | 3064.75 USD — | — - | — — |
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3090.39 USD — |
-0.26
|
— — | 3063.94 USD — | 3108.39 USD — | — - | — — |
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
- {{ link.label }} {{link}}


